PBX4 and neoplasm: RT-qPCR and RNA in situ hybridization verified the expression of AKT2-PBX4, AKT2-ZNF546 and PIK3R1-CCDC178 fusions in tumor specimens (Fig. 1D and E, Supplementary Fig. S3).